ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 645621 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 645621; 2) Community: the network communities that were significantly associated with the response to NSC 645621; 3) Molecule: the relationships between components within communities and NSC 645621; 4) MDR: the compounds that were significantly associated with the NSC 645621.

NSC Compound Enrichment Correlation
NSC 743221 N3-(4-chloro-3-methylphenyl)-N2-(4-fluorophenyl)-5-oxo-7-pro pyl-5H-[1,3]thiazolo[3,2-a]pyrimidine-2,3-dicarboxamide 0.0278435641331418 0.20024954
NSC 26040 1-Piperidineethanol, .alpha.-[p-(p-chlorostyryl)phenyl]- 0.027843564133142 0.31763117
NSC 696864 Null 0.0278435641331422 0.41331837
NSC 759877 Dasatinib (USAN) 0.0304779558345019 -0.15172808
NSC 740644 6-(3-Bromopropyl)-9-ethoxy-5,6-dihydro-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0304779558345021 0.074834246
NSC 201863 N-[1-(Biphenyl-4-yl)ethyl]-3,4-dichlorobenzamide 0.0306776553926119 -0.15571238
NSC 269757 BACCHARIN 0.0306776553926119 0.41546575
NSC 46691 Null 0.0306776553926119 -0.1660762
NSC 638388 Null 0.0306776553926119 0.54491272
NSC 642049 Acetamide, N-(3-acetylphenyl)-2-[(4-amino-5-mercapto- 4H-1,2,4-triazol-3-yl)hydrazino]-2-oxo- 0.0306776553926119 0.52529681
Total:56  Current:30    [First] [Prev] [Next] [Last]